Matrix parent buys Aspen's share in Astrix Laboratories
In a move cheered by investors, Indian pharmaceuticals firm Matrix has persuaded its US-based parent Mylan Laboratories to purchase Aspen's stake in the Astrix joint venture.
January 15, 2009
